VEVArx sells sermorelin, glutathione and NAD+ in three-month blocks only, and prints the prepaid total next to its own per-month equivalent. PT-141 is the one product you can also buy a month at a time.
By Nora Castellan, Standards EditorUpdated September 2026
1.7 / 10
Disclosure score, 6 checks
Best fora buyer comfortable prepaying a quarter who wants the monthly equivalent shown, not implied
What VEVArx charges
Sermorelin$399 — total for three months of careSermorelin, three-month plan
Sermorelin$133/mo — the seller’s own stated equivalent of its $399 three-month planSermorelin, per-month equivalent
Glutathione$117/mo — the seller’s own stated equivalent of its $349 three-month planGlutathione, per-month equivalent
NAD+$133/mo — the seller’s own stated equivalent of its $399 three-month planNAD+, per-month equivalent
PT-141$247/mo — per month on the flexible monthly plan; the three-month plan is $663 total, stated as $221/monthPT-141, monthly program
What VEVArx publishes
Not disclosedNames the pharmacy that fills it
PublishedPublishes a price before intake
Not disclosedShips to all 50 states
Not disclosedIncludes lab work in the price
Not disclosedNames the clinician who prescribes
Not disclosedStates whether a membership fee applies
Cancellation, refunds and shipping
What VEVArx states on its own site about leaving, getting money back, and what delivery costs. Read on September 2026.
StatedCancellation: "Once the initial medical intake has been submitted, the order is considered processed and is non-refundable" — the window closes at intake submission, before any provider review. The homepage FAQ asks "What is your subscription and refund policy?" and the answer is a collapsed accordion that does not render.
StatedRefund: "Refunds are granted only under the following two circumstances": a provider finding the patient medically ineligible at the initial consultation, or a billing error by the seller such as a duplicate or incorrect charge. This is Peptivo's policy word for word — a second seller on that template.
StatedShipping: Shipping is priced into each named package — every tier "includes the Telehealth consultation, prescription, GLP-1 medication, shipping, and ongoing medical support" — so there is no separate charge, though no delivery window or carrier is published.
Membership fees
Whether VEVArx charges to belong, on top of what it charges for the medication. Read on September 2026.
Not statedVEVArx publishes nothing about a membership on any page we checked.
Who prescribes
Whether VEVArx identifies the clinician or medical practice behind the prescription, or describes them only as a group. Read on September 2026.
Not namedVEVArx does not name a prescriber on any page we checked — its clinicians are described as a group rather than identified.
VEVArx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Each product card names a three-month plan, gives the total, and states the per-month equivalent VEVArx has worked out for you.
Both numbers are on the card, so you can line the plan up against a monthly seller without dividing anything yourself.
What leaves your account, though, is the quarter, in full and up front.
PT-141 is the exception
PT-141 is sold on a flexible monthly plan as well as a three-month one, with the monthly figure stated per month and the three-month total carrying its own equivalent.
So it is the one product you can try before committing to a quarter.
Sermorelin, glutathione and NAD+ have no monthly option published at all.
What the money covers
The cards list what you get — a licensed provider evaluation, the treatment plan if prescribed, delivery and ongoing support — rather than only what it costs.
VEVArx states plainly that compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness or quality.
It also warns that its charts are illustrative and its product images may not match what arrives, which is more candor than this category usually offers.
The blanks
No operating company appears on any page read, so there is no business name to look up.
No list of served states is published, and no dispensing pharmacy is named.
No certificate of analysis is reachable, and nothing in the federal warning-letter record attaches to the brand.
Who VEVArx suits
Who it's for
Buyers comfortable prepaying a quarter for a lower monthly equivalent.
Readers who want the per-month figure printed rather than implied.
Shoppers who want PT-141 available month to month.
Anyone who wants a plan's inclusions listed beside its price.
Who should look elsewhere
Readers who want sermorelin, glutathione or NAD+ a month at a time.
Buyers who need a named company or pharmacy.
Anyone who needs a published state list.
Shoppers who want published testing.
Strengths and trade-offs
Strengths
Prints the prepaid total and the per-month equivalent on the same card
Offers PT-141 month to month as well as on a three-month plan
States plainly that compounded medications are not approved by the FDA
Lists what each plan includes rather than only what it costs
Trade-offs
Sells sermorelin, glutathione and NAD+ only in three-month blocks
Publishes no operating company on any page read
Publishes no state list and names no dispensing pharmacy
No certificate of analysis is reachable
How we verified this
Each product page was read in September 2026, and every card prints the prepaid total beside VEVArx's own per-month equivalent.
PT-141 is published with a monthly plan as well as a three-month one; the other three compounds are not.
Each plan states what it includes rather than only what it costs.
No operating company, state list or named dispensing pharmacy appears on any page read.
The brand was checked against the federal warning-letter database in September 2026.
A provider to compare VEVArx against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
